Atezolizumab,Bevacizumab
Roche
['bevacizumab', 'atezo']
patients who received atezolizumab plus bevacizumab had their risk of recurrence or death reduced by 28% compared with patients who underwent active surveillance. #aacr23
The mission of the American Association for Cancer Research is to prevent and cure cancer through research, education, communication, and collaboration.